Hillstream BioPharma, Inc. (HILS)

NASDAQ: HILS · IEX Real-Time Price · USD

0.600

+0.061 (11.23%)

At close: Jan 27, 2023, 4:00 PM

0.629

+0.029 (4.90%)

After-hours: Jan 27, 2023, 7:16 PM EST

HILS has decreased by -84.33% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 7 stock analysts, the average 12-month stock price forecast for HILS stock is $6.12, which predicts an increase of 920.00%. The lowest target is $6.06 and the highest is $6.3. On average, analysts rate HILS stock as a buy.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6.06	$6.12	$6.12	$6.3
Change	+910.00%	+920.00%	+920.00%	+950.00%

Analyst Ratings

The average analyst rating for HILS stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '22	Sep '22	Oct '22	Nov '22	Dec '22	Jan '23
Strong Buy	2	2	2	2	2	2
Buy	4	4	4	4	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.